Why don't we do more rigorous clinical research so that we can stop experimenting on patients?

Journal of Palliative Medicine

Volumn 13, Issue 6, 2010, Pages 636-637

  Currow, David C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; DISEASE COURSE; EDITORIAL; EVIDENCE BASED MEDICINE; EXPERIMENTAL STUDY; HEALTH CARE QUALITY; HUMAN; MEDICAL ETHICS; PALLIATIVE THERAPY; COMPARATIVE EFFECTIVENESS; ETHICS; HUMAN EXPERIMENT; MEDICAL RESEARCH; METHODOLOGY;

BIOMEDICAL RESEARCH; COMPARATIVE EFFECTIVENESS RESEARCH; HUMAN EXPERIMENTATION; HUMANS; RESEARCH DESIGN;

EID: 77954437472     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2010.9824     Document Type: Editorial

References (7)

1. Pavis H, Wilcock A: Prescribing of drugs for use outside their licence in palliative care: survey of specialists in the United Kingdom. Br Med J 2001;323:484-485.
2. Bach JR: Palliative care becomes 'uniformed euthanasia' when people are not offered noninvasive life preserving options. J Palliat Care 2007;23(3):181-184.
3. Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby- James TM: Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007;55(4):590-595.
4. White C, Hardy J: What do palliative care patients and their relatives think about research in palliative care? A systematic review. Support Care Cancer [Epub ahead of print 2009August 25].
5. Tieman J, Sladek R, Currow DC: Changes in the quantity and level of evidence of palliative and hospice care literature: the last century. J Clin Oncol 2008;26(35):5679-5683.
6. Anonymous: NHMRC additional levels of evidence and grades for recommendations for developers of guidelines- Stage 2 pilot. Available at www.nhmrc.gov.au/guidelines/ consult/consultations/add-levels-grades-dev- guidelines2 .htm. Accessed February 3, 2010.
7. Berwick DM: Disseminating innovations in health care. JAMA 2003;289:1969-1975.